Europe Influenza Vaccines Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Influenza Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Influenza Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Influenza Vaccines Market Regional Analysis

6.2 Europe Influenza Vaccines Market Revenue 2020-2028 (US$ Million)

6.3 Europe Influenza Vaccines Market Forecast Analysis

7. Europe Influenza Vaccines Market Analysis – by Vaccine Type

7.1 Quadrivalent Vaccines and Trivalent Vaccines

7.1.1 Overview
7.1.2 Quadrivalent Vaccines and Trivalent Vaccines: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Influenza Vaccines Market Analysis – by Virus Type

8.1 Influenza Virus Type A and Influenza Virus Type B

8.1.1 Overview
8.1.2 Influenza Virus Type A and Influenza Virus Type B: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Influenza Vaccines Market Analysis – by Technology

9.1 Egg-based and Cell-based

9.1.1 Overview
9.1.2 Egg-based and Cell-based: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Influenza Vaccines Market Analysis – by Route of Administration

10.1 Injection and Nasal Spray

10.1.1 Overview
10.1.2 Injection and Nasal Spray: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Europe Influenza Vaccines Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Influenza Vaccines Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Europe Influenza Vaccines Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.1.2 UK: Europe Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.1.3 UK: Europe Influenza Vaccines Market Breakdown, by Technology
11.2.1.1.4 UK: Europe Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.2 Germany: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.2.2 Germany: Europe Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.2.3 Germany: Europe Influenza Vaccines Market Breakdown, by Technology
11.2.1.2.4 Germany: Europe Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.3 France: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.3.2 France: Europe Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.3.3 France: Europe Influenza Vaccines Market Breakdown, by Technology
11.2.1.3.4 France: Europe Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.4 Russia: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.4.2 Russia: Europe Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.4.3 Russia: Europe Influenza Vaccines Market Breakdown, by Technology
11.2.1.4.4 Russia: Europe Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.5 Italy: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.5.2 Italy: Europe Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.5.3 Italy: Europe Influenza Vaccines Market Breakdown, by Technology
11.2.1.5.4 Italy: Europe Influenza Vaccines Market Breakdown, by Route of Administration

11.2.1.6 Rest of Europe: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
11.2.1.6.2 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Virus Type
11.2.1.6.3 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Technology
11.2.1.6.4 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Route of Administration

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 AstraZeneca

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Emergent BioSolutions Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 GlaxoSmithKline plc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Mitsubishi Chemical Group Corporation

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Moderna, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 MYLAN N.V.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Sanofi

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 SEQIRUS

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Serum Institute of India Pvt. Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Influenza Vaccines Market

Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)